[ Price : $8.95]
A new report from IMS Institute for Healthcare Informatics recommends that FDA or the healthcare industry establish an early warni...[ Price : $8.95]
Federal Register Notice: FDA seeks comments on information collection requirements for reclassification petitions for medical devi...[ Price : $8.95]
Federal Register Notice: FDAs Advisory Committee for Reproductive Health Drugs will meet 1/20/12 to discuss Columbia Labs NDA for ...[ Price : $8.95]
Genzyme says it will submit an NDA during the first quarter of 2012 for its multiple sclerosis therapy Lemtrada following favorabl...[ Price : $8.95]
FDA review documents released before an advisory committee meeting appear to support expanded use of Wyeths Prevnar 13 in adults a...[ Price : $8.95]
FDA commissioner Margaret Hamburg telsl cancer researcher FDA is finalizing a guidance on streamlining data collection in late sta...[ Price : $8.95]
FDA says it is keeping a close eye on fatal bleeding cases associated with Boehringer Ingelheims Pradaxa, indicated for preventing...[ Price : $8.95]
In what may be the latest example of FDAs dwindling transparency, the FDA Alumni Association forbids news media coverage of its me...